27th Jan 2005 07:01
Advanced Medical Solutions Grp PLC27 January 2005 For Immediate Release Thursday, 27 January 2005 Advanced Medical Solutions Group plc ("AMS" or "the Company") Inclusion on contract to supply wound management products to NHS Hospitals in Scotland Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, is pleased to announce that it has been selectedby Scottish Healthcare Supplies, the procurement service to the NHS in Scotland,for inclusion on a contract for supply of woundcare products. The award followsan in-depth technical and clinical evaluation in a major Scottish NHS HospitalTrust and covers a range of AMS' advanced wound dressings, which will be soldunder the ActivHeal(R) brand by the Company's MedLogic direct sales andmarketing team. The inclusion of ActivHeal(R) is a response to cost constraints on woundcarebudgets whereby savings made on standard products for routine wounds allowfunding of higher technology products for problematic wounds. AMS' strategy isto fulfil the demand for these standard products by selling either directly, asin the UK, or via private label partners whilst continuing to sell itsdifferentiated products through its major woundcare partners under their leadingbrands. As a UK-based technology company, AMS is ideally placed to become a newgeneration woundcare supplier through a balance of innovation and costmanagement by integrating with the end user. This benefits both parties andallows significant cost savings to be achieved by the NHS along the lines of thehighly successful generic pharmaceutical model. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS, said: "I am delighted that we have been selected for the supply of our products intoNHS hospitals in Scotland. This is another major step forward in strengtheningour UK presence as part of broadening our routes to market. "Following on from the inclusion of our products on the NHS contract forhospitals in England announced in December 2004, and previous Drug Tariffapprovals allowing our products to be prescribed in England, Wales and Scotland,this latest award means that our ActivHeal(R) woundcare brand is now widelyavailable for sale into hospitals, nursing homes and community care throughoutthe NHS in the UK." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets with strategic partners including 3M, Novartis, Johnson & Johnson,Molnlycke Healthcare, Smith + Nephew and Cardinal Health. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group